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On the Signiﬁcance of Linkage Studies of Complex
Traits
To the Editor:
We read with interest the recent article by Wang et al.
(2004) reporting linkage of premature myocardial infarc-
tion (MI) to a locus on 1p34-36. The authors have re-
cruited a large sample of families with premature coro-
nary artery disease (CAD), as detected by catheterization,
revascularization, or MI. Such large-scale approacheswill
be crucial to the identiﬁcation of genetic variation under-
lying complex traits, including atherosclerotic CAD and
MI, the leading killer of men and women in the Western
world. We commend the authors for undertaking such
an important study.
Although their article reports the nominal LOD score
of 11.68 for linkage of premature MI to 1p34-36 and
a corrected pointwise P value of .00011, we note that
the genomewide signiﬁcance of the linkage statistic is not
clear. We have some methodological concerns regarding
the initial emphasis on results presented in their table 2
and ﬁgure 1:
1. The ﬁnding of 11 independentlog10P values 13.13
in the multipoint linkage approach (regions identiﬁed in
single-point and multipoint W2 analyses overlap signiﬁ-
cantly) raises questions regarding the assertion that such
a threshold corresponds to a LOD score 12.2, as pro-
posed by Lander and Kruglyak (1995). A LOD score 12.2
should occur once in a maximally informative genome-
wide scan, under the null hypothesis that no genetic link-
age is present. It seems unlikely that 11 true genetic loci
inﬂuencing a complex phenotype would be detected in a
single study. It is more likely that the asymptotic P value
statistic generated by the authors’ modiﬁed Haseman-
Elston regression model is inﬂated.
2. The marked attenuation of the multipoint P value
of !1012 to 104 on pointwise permutation testing at
the 1p34-36 locus suggests that the nominal asymptotic
P values are inﬂated. It is possible that the method of
linkage analysis may have inﬂated the P value estimates.
In particular, the treatment of the dichotomous MI phe-
notype as a continuous variable may not be appropriate.
The assumption of equal variances required for a quan-
titative trait may not be valid for different numbers of
affected and unaffected individuals in each family.
3. The authors’ attempt to correct the pointwise em-
pirical P value estimates for the number of markers tested
is quite important for establishing the signiﬁcance of their
ﬁndings. However, the attempt may be inadequate to
account for the testing of multiple markers. The authors
refer to the simulation analyses byWiltshire et al. (2002),
which explored the inﬂuence of experimental deviations
from the Lander-Kruglyak assumptions of completely in-
formative linkage analyses. We are uncertain whether the
empirical genomewide P value estimates derived from
the Wang et al. (2004) data correspond to the same
nominal LOD-score thresholds identiﬁed in theWiltshire
et al. (2002) study using simulated data. Permutation
testing of the Wang et al. (2004) data by use of the
Wiltshire approach might provide greater conﬁdence re-
garding the genomewide signiﬁcance of the study ﬁnd-
ings, but this approach admittedly represents a signiﬁ-
cant computational burden.
4. Genomewide linkage analyses at 10 cM may not
extract maximally the identity-by-descent information for
the sample under study. A ﬁne-mapping study at higher
density across a region of interest may show a change in
the maximum-LOD-score estimate. An increase in the
LOD-score estimate with better information extraction
might be reassuring, but a fall in the LOD score may
signal a false-positive ﬁnding. We would encourage the
authors to perform and publish the results of a higher-
density map.
5. The study cohort was recruited on the basis of a
composite deﬁnition of premature CAD.Was the broader
CAD phenotype (including MI) the primary phenotype
prespeciﬁed in the linkage analysis? The reported MI
linkage analysis represents a subgroup of the subjects
enrolled; the “less-restrictive” CAD phenotype was also
tested and revealed no suggestive or signiﬁcant linkage
evidence. Could the authors clarify their original pri-
mary analysis and whether additional subgroups were
analyzed? A true empirical P value would also account
for the multiple phenotypes tested.
On review of the study, the declaration of a ﬁnding
of genomewide signiﬁcance may not be as strongly sup-
ported as suggested by the authors. The results of this
linkage analysis do not contain much overlap with those
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of similar analyses, and this certainly could result from
differences in phenotype deﬁnition, environmental expo-
sures, or study design (Pajukanta et al. 2000; Francke
et al. 2001; Broeckel et al. 2002; Harrap et al. 2002;
Chiodini and Lewis 2003). Replication of linkage analy-
ses for complex cardiovascular traits has often proven
challenging, and the difﬁculty in achieving replication for
MI underscores the many difﬁculties in the conduct and
interpretation of such linkage analyses (Altmuller et al.
2001).
Identifying genetic factors underlying linkage peaks in
this and related studies of MI will require considerable
expenditure of resources and should proceed on the basis
of the strongest possible evidence. We encourage the sys-
tematic comparison of available and accruing linkage
data across studies in various CAD phenotypes, includ-
ing continued assessment of the most appropriate link-
age methods.
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Reply to Newton-Cheh et al.
To the Editor:
Newton-Cheh et al. (2004 [in this issue]) raise the issue
of some methodological concerns in our genomewide-
scan study that identiﬁed signiﬁcant linkage on chromo-
some 1p34-36 for premature myocardial infarction (MI).
We would like to systematically address their concerns.
First, we do explicitly report that the genomewide sig-
niﬁcance for the chromosome 1p34-36 linkage as P !
( –.038), derived fromWiltshire et al. (2002)..05 Pp .030
This point was duly emphasized in the abstract and the
“Results” and “Discussion” sections (Wang et al. 2004).
Second, with respect to the high number of loci with as-
ymptotic P values (pP) that were suggestive of linkage,
we performed permutation tests and reported empirical
P values. As we reported, only the chromosome 1p34-36
locus fulﬁlled the criteria of genomewide signiﬁcance.
Third, MI is a dichotomous phenotype. Either patients
have an MI or do not have this acute ischemic event. As
reported by Altmuller et al. (2001), studies of 101 ge-
nomewide scans in 31 different diseases revealed that
quantitative “intermediate” traits did not have any ad-
vantages over dichotomous traits for linkage analysis.
Furthermore, several methodological investigations indi-
cated that, in practice, treatment of ordinal (or binary)
data as continuouswith standard linearmodels for genetic
mapping of categorical traits is feasible, with marginal
